Page last updated: 2024-09-03

n-hydroxysuccinimide s-acetylthioacetate and Cerebral Malaria

n-hydroxysuccinimide s-acetylthioacetate has been researched along with Cerebral Malaria in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crommelin, DJ; Eling, WM; Hermsen, RC; Postma, NS; Zuidema, J1

Other Studies

1 other study(ies) available for n-hydroxysuccinimide s-acetylthioacetate and Cerebral Malaria

ArticleYear
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Animals; Humans; Injections, Intravenous; Malaria, Cerebral; Mice; Plasmodium berghei; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Succinimides; Sulfhydryl Reagents; Sulfides; Tumor Necrosis Factor-alpha

1999